Direct Mobilization After Successful Femoral Deployment of an Angio‐Seal VIP Following a Coronary Procedure: The MOVE‐IT Pilot Study
Journal of Interventional Cardiology · 2026-01 · 2026 (1)
DOI: 10.1155/joic/8162438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interventional Cardiology, online erschienen am 20.11.2026. Verfasst von R. L. I. Jonkman und 10 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Mobilisation
Abstract (Originalsprache)
Background
Routine postprocedural immobilization after transfemoral coronary procedures (TCPs) aims to prevent vascular complications but may delay recovery and prolong hospitalization. With contemporary vascular closure devices, the necessity of immobilization is increasingly questioned. The MOVE‐IT pilot study evaluated the safety and feasibility of direct mobilization after TCP using Angio‐Seal VIP–mediated femoral artery closure. This evaluation is relevant given the limited evidence supporting direct mobilization in contemporary TCP patients, especially those receiving increasingly potent antithrombotic therapy or undergoing procedures requiring larger sheath sizes.
Methods
This prospective, single‐center pilot study included 50 consecutive patients undergoing transfemoral coronary angiography (CAG) or percutaneous coronary intervention (PCI) using 6–8 Fr sheaths. Patients were mobilized directly after successful Angio‐Seal VIP deployment. The primary outcome was a composite endpoint of access‐site bleeding (BARC Types 2, 3, and 5), minor (< 5 cm) and major (≥ 5 cm) hematomas, vascular complications, vascular interventions, and vasovagal reactions. A stopping rule based on a 10% incidence of BARC Type 3 bleeding was incorporated. Secondary outcomes included time to discharge, patient satisfaction, and pain scores. Outcomes were assessed immediately after the procedure, at 1 and 2 h, and at 30‐day follow‐up.
Results
Mean age was 68.2 ± 9.1 years; 26% were female, and 50% underwent PCI. A 6 Fr sheath was used in 84% of patients. Mean arterial pressure before Angio‐Seal VIP deployment was 96.8 ± 2.3 mmHg. The median ACT was 228 s (IQR 198–264). The primary composite endpoint occurred in 23 patients (46%), comprising a total of 28 component events, predominantly driven by hematomas. Hematomas were observed in 23 patients, BARC Type 2 bleeding in 4 patients, and a vasovagal reaction in 1 patient. All BARC Type 2 bleeding events and the vasovagal reaction occurred in patients who also had a major hematoma. No BARC ≥ 3 bleedings, vascular complications, or vascular interventions occurred. Mean time to discharge was 3.0 ± 1.3 h. Patient‐reported outcomes showed high satisfaction (mean 9.0/10) and low pain scores (VAS < 1/10).
Conclusions
This small exploratory pilot study suggests that direct mobilization after TCP using Angio‐Seal VIP was feasible in this selected cohort, with no major bleeding or vascular complications observed, warranting further evaluation in comparative studies.
Zitieren
APA
Jonkman, R. L. I., Ponsioen, E. L. M., Claessen, B. E. P. M., Nap, A., Verouden, N. J., Lemkes, J. S., Appelman, Y., Opstal, T. S. J., Knaapen, P., Delewi, R., & Hartog, A. W. D. (2026). Direct Mobilization After Successful Femoral Deployment of an Angio‐Seal VIP Following a Coronary Procedure: The MOVE‐IT Pilot Study. Journal of Interventional Cardiology, 2026(1). https://doi.org/10.1155/joic/8162438
Vancouver
Jonkman RLI, Ponsioen ELM, Claessen BEPM, Nap A, Verouden NJ, Lemkes JS, et al. Direct Mobilization After Successful Femoral Deployment of an Angio‐Seal VIP Following a Coronary Procedure: The MOVE‐IT Pilot Study. Journal of Interventional Cardiology. 2026;2026(1). doi:10.1155/joic/8162438
BibTeX
@article{Jonkman2026,
author = {Jonkman, R. L. I. and Ponsioen, E. L. M. and Claessen, B. E. P. M. and Nap, A. and Verouden, N. J. and Lemkes, J. S. and Appelman, Y. and Opstal, T. S. J. and Knaapen, P. and Delewi, R. and Hartog, A. W. Den},
title = {Direct Mobilization After Successful Femoral Deployment of an Angio‐Seal VIP Following a Coronary Procedure: The MOVE‐IT Pilot Study},
journal = {Journal of Interventional Cardiology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/joic/8162438}
}
EUVIMED